An interventional study of CPOE with order sets for lab testing and CPOE without order sets for lab testing in Diabetes Mellitus, Hypertension and Cardiovascular Diseases, sponsored by Universitaire Ziekenhuizen KU Leuven. Completed at 1 site in Belgium. Per ClinicalTrials.gov, last updated 2020-01-23.
Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Diagnostic
Cluster randomised controlled trial to evaluate what the effect is of evidence-based order sets aimed at five indications on the appropriateness of laboratory test ordering in primary care.
Cluster randomised controlled trial in Belgian primary care practices. Participants will be primary care physicians working in primary care practices affiliated to one of three collaborating laboratories in the Leuven, Ghent or Antwerp regions.
Primary care practices will be allocated and randomized to either the intervention or control group. Physicians in PCPs randomized to the intervention will be offered order sets based on indication when using the CPOE for ordering laboratory tests. The effect of order sets will be analyzed for 17 common indications for ordering laboratory tests in Belgian primary care: diabetes mellitus, hypertension, cardiovascular disease, general check-up, unexplained fatigue, anemia, liver pathology, medication monitoring, gout, chronic kidney disease, lung embolism, acute coronary syndrome, diarrhea, thyroid disease, sexually transmitted disease, rheumatoid arthritis and obesity.
424 studies on the registry are indexed under Sexually Transmitted Diseases; 71 are open to participants now.
This study's enrollment of 288 is below the median of 470 across 346 interventional studies indexed under Sexually Transmitted Diseases.
Browse Sexually Transmitted Diseases studies →Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 928 studies on the registry; 261 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
All family physicians will be considered eligible if they:
Exclusion Criteria:
Physicians who use CPOE including order sets for large range of indications.
Other: CPOE with order sets for lab testing
Physicians who use CPOE without order sets.
Other: CPOE without order sets for lab testing
CPOE including series of recommended tests ordered per indication
Also known as: CPOE with order sets for laboratory testing
CPOE only
Also known as: CPOE without order sets for laboratory testing
Appropriateness
number of appropriate tests for 17 study indications
Time frame: 3 months
Missed or delayed diagnoses
Incidence of missed or delayed diagnoses after laboratory test
Time frame: 1 year
Laboratory test volume
Total volume of ordered laboratory tests
Time frame: 1 year
Downstream or cascade clinical activities
All downstream or cascade clinical activities as a result of abnormal test result
Time frame: 1 year
Documents are hosted by the registry — open the source record to download them.
Plan to share: No — IPD sharing plan not yet decided. Decision will be made upon start of trial.
This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sexually Transmitted Diseases→
Universitaire Ziekenhuizen KU Leuven